🚀 RECENT AI SUCCESS
Our AI successfully predicted the gap for $SFIX and executed a BUY strategy, securing a +31.52% net profit.
UPGRADE TO SEE LIVE SIGNALS
$BAVA.CO
Bavarian Nordic A/S
FREE PREVIEW
📅 Next Earnings: Aug 21, 2026 🌙 Close🌐 Website🏛️ Nasdaq Copenhagen📁 Health Technology🏭 Biotechnology
AVG HISTORICAL GAP0.46%
MAX GAP RECORD-12.11%
PREMIUM
AI ACCURACY RATE92.4%
Unlock AI Insights 🔓LAST 10 EARNINGS GAPS (%)
VOLATILITY & BIAS PROFILE
AVG VOLATILITY4.5%
Bullish Gaps
Bearish Gaps
Neutral
Intelligence Brief
Bavarian Nordic A/S engages in the business of developing, manufacturing, and commercializing cancer immunotherapies and vaccines for infectious diseases. The firm is involved in cancer immunotherapy including cancer pipeline, which focuses on therapeutic vaccines for breast, lung, ovarian, and prostate cancer. The company was founded on July 1, 1992 and is headquartered in Hellerup, Denmark. Read full dossier
CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL